期刊
ANNUAL REVIEW OF MEDICINE, VOL 69
卷 69, 期 -, 页码 97-111出版社
ANNUAL REVIEWS
DOI: 10.1146/annurev-med-041316-090622
关键词
cardiotoxicity; cardio-oncology; risk factors; heart failure; biomarkers; survivorship
There is growing awareness of the overlap between oncologic and cardiovascular (CV) diseases, including a wide range of CV effects of anticancer therapies. As novel anticancer therapeutics become available and cancer survival outcomes improve, the CV implications of cancer therapy become increasingly important. In addition to outlining the CV effects of commonly used cancer therapies and their consequences for long-term survivorship, this review highlights the recent efforts to improve the risk prediction and prevention of CV toxicity through the evaluation of sensitive measures for early toxicity detection and the implementation of cardioprotective strategies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据